Qube Research & Technologies Ltd - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 70 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.0%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$61,557
+1227.8%
64,122
+409.6%
0.00%
Q4 2022$4,636
-91.3%
12,582
-89.9%
0.00%
Q3 2022$53,000
-56.2%
124,369
-19.6%
0.00%
-100.0%
Q2 2022$121,000
+116.1%
154,597
+250.3%
0.00%
Q4 2021$56,000
-82.3%
44,132
-47.6%
0.00%
-100.0%
Q2 2021$316,000
+496.2%
84,158
+446.5%
0.00%
+300.0%
Q4 2020$53,000
-75.5%
15,400
-71.0%
0.00%
-66.7%
Q3 2020$216,00053,0220.00%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Piermont Capital Management Inc. 312,842$2,033,0000.48%
BARD ASSOCIATES INC 648,525$4,215,0000.39%
Sonora Investment Management, LLC 233,295$1,516,418,0000.30%
Nine Chapters Capital Management LLC 32,400$211,0000.28%
Alambic Investment Management, L.P. 287,601$1,869,0000.23%
Granite Investment Partners, LLC 201,221$1,308,0000.09%
Renaissance Technologies 5,679,800$36,919,0000.05%
PDT Partners, LLC 123,200$801,0000.04%
ClariVest Asset Management LLC 242,050$1,573,0000.04%
KENNEDY CAPITAL MANAGEMENT LLC 315,934$2,054,0000.04%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders